Vytone Interactions
There are 48 drugs known to interact with Vytone (hydrocortisone/iodoquinol topical), along with 9 disease interactions. Of the total drug interactions, 1 is major, and 47 are moderate.
- View all 48 medications that may interact with Vytone
- View Vytone disease interactions (9)
Most frequently checked interactions
View interaction reports for Vytone (hydrocortisone / iodoquinol topical) and the medicines listed below.
- acetaminophen
- acetaminophen / oxycodone
- Aczone (dapsone topical)
- Afrin (oxymetazoline nasal)
- albuterol
- alprazolam
- Aspir 81 (aspirin)
- aspirin
- atorvastatin
- Augmentin (amoxicillin / clavulanate)
- Celebrex (celecoxib)
- CeraVe (emollients topical)
- Chloraseptic Sore Throat Spray (phenol topical)
- clobetasol topical
- Cloderm (clocortolone topical)
- Colace (docusate)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Diflucan (fluconazole)
- escitalopram
- fluocinonide topical
- ketoconazole topical
- metoprolol
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- prednisone
- tramadol
- Tylenol (acetaminophen)
- Zoloft (sertraline)
- Zyrtec (cetirizine)
Vytone disease interactions
There are 9 disease interactions with Vytone (hydrocortisone / iodoquinol topical) which include:
- hepatic dysfunction
- thyroid dysfunction
- visual field defects
- peripheral neuropathy
- diabetes
- diaper rash
- hyperadrenocorticism
- infections
- ocular toxicities
Report options
QR code containing a link to this page
More about Vytone (hydrocortisone / iodoquinol topical)
- Vytone consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- Drug class: topical steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.